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Abstract
Background: Caspase-independent apoptotic pathways are suggested as a mechanism for the
delayed neuronal death following ischemic insult. However, the underlying signalling mechanisms
are largely unknown. Recent studies imply the involvement of several mitochondrial proteins,
including endonuclease G (EndoG) and Bcl-2/adenovirus E1B 19 kDa-interacting protein (BNIP3),
in the pathway of non-neuronal cells.
Results: In this report, using western blot analysis and immunocytochemistry, we found that
EndoG upregulates and translocates from mitochondria to nucleus in a time-dependent manner in
cultured hippocampal neurons following oxygen-glucose deprivation (OGD). Moreover, the
translocation of EndoG occurs hours before the observable nuclear pyknosis. Importantly, the
mitochondrial upregulation of BNIP3 precedes the translocation of EndoG. Forced expression of
BNIP3 increases the nuclear translocation of EndoG and neuronal death while knockdown of
BNIP3 decreases the OGD-induced nuclear translocation of EndoG and neuronal death.
Conclusion: These results suggest that BNIP3 and EndoG play important roles in hippocampal
neuronal apoptosis following ischemia, and mitochondrial BNIP3 is a signal protein upstream of
EndoG that can induce neuronal death.
Background
The hippocampus, a very important structure for learning
and memory, is among the most vulnerable brain regions
after global cerebral ischemia. The rapid decrease of oxy-
gen and glucose in the ischemic region can trigger delayed
neuronal death [1], and reperfusion may further exacer-
bate the injury. The delayed cell death occurs primarily
through an apoptotic mechanism [2]. Evidence has
accumulated that a large proportion of the delayed neuro-
nal death is mediated by caspase-independent pathways
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[3-5]. However, the signalling mechanisms remain largely
unclear. Recent studies have implicated mitochondrial
proteins, such as endonuclease G (EndoG) and Bcl-2/ade-
novirus E1B 19 kDa-interacting protein (BNIP3), as play-
ers involved in this pathway in non-neuronal cells [6].
EndoG is an endonuclease normally localized in the mito-
chondrial intermembrane space, and translocates to the
nucleus when cells are exposed to an apoptosis-inducing
stimulus. After moving to the nucleus, EndoG cleaves
chromatin DNA into nucleosomal fragments independ-
ent of caspases [7]. The compartmentalization of mito-
chondria plays the major role in EndoG trafficking. The
EndoG location site might indicate that this enzyme is not
an instrument for immediate response to cell injury [8].
BNIP3 is a member of a unique family of death-inducing
mitochondrial proteins [9]. In neurons, the expression of
BNIP3 is undetectable under normal conditions [10] but
can be induced by hypoxia/ischemia and oxidative stress
[11,12]. The BNIP3-induced non-neuronal cell death is
characterized by mitochondrial damage but is independ-
ent of caspase activation and cytochrome c release [10]. It
is presently unclear how BNIP3 initiates neuronal death.
In this study, we profiled BNIP3 and EndoG expression
and translocation in cultured hippocampal neurons fol-
lowing oxygen-glucose deprivation (OGD). We demon-
strate here that EndoG upregulates and translocates from
mitochondria to nucleus in a time-dependent manner.
Moreover, the translocation of EndoG occurs hours before
the observable nuclear pyknosis. Importantly, we investi-
gated the causal relationship between mitochondrial
BNIP3 upregulation and EndoG translocation and
nuclear pyknosis by over expressing or knocking down of
BNIP3. Our findings strongly support a role for BNIP3 as
a signal protein upstream of EndoG leading to the induc-
tion of neuronal death.
Results
OGD induces EndoG upregulation in primary neuronal 
cultures
Primary rat hippocampal neurons at day 12 in vitro were
subjected to OGD for 4 h and reoxygenation for 0 h, 2 h,
6 h, 12 h and 24 h. Normal cultured control and EBSS-
treated neurons under normoxic condition were set as
controls. Levels of EndoG expression were determined by
western blot analysis. EndoG immunoreactivity was iden-
tified as the ~35 kDa protein band in the whole cell frac-
tion after treatment. Immunoblotting with a monoclonal
β-actin antibody was performed as standards for calcula-
tion of EndoG expression. As shown in Figure 1, total
amount of EndoG did not vary until reoxygenation was
prolonged to 6 h and accumulated to the highest level at
12 h of reoxygenation.
EndoG translocates from the mitochondria to the nucleus 
after reoxygenation
We next examined the subcellular localization of EndoG
to determine whether OGD could induce the transloca-
tion of EndoG. Mitochondrial and nuclear fractions were
prepared by differential centrifugation. Cox IV antibody
for mitochondrial and histone H3 antibody for nuclear
fractions were used as sample loading controls. EndoG
level in the mitochondrial fraction began to decrease sig-
nificantly at 2 h of reoxygenation and further decreased
with time exposed to reoxygenation (Figure 2A and 2B).
Meanwhile, EndoG in nuclear fraction showed a signifi-
cant increase at the corresponding time point and accu-
mulated with increased periods of reoxygenation (Figure
2C and 2D). These data suggest that the released EndoG
from mitochondria translocates to nucleus.
Nuclear EndoG translocation precedes OGD-induced 
neuronal death
To evaluate the role of nuclear EndoG translocation in
OGD, we investigated the relation between EndoG trans-
location and cell death. At different time points after reox-
Upregulation of EndoG expression in reoxygenated hippoc- ampal neuronal cultures following OGD Figure 1
Upregulation of EndoG expression in reoxygenated 
hippocampal neuronal cultures following OGD. (A) 
Representative western blot showing the expression of 
EndoG. (B) Quantification of the expression of EndoG. Data 
were presented as fold of the control group. *p < 0.05 vs. 
control group, n = 6.BMC Neuroscience 2009, 10:113 http://www.biomedcentral.com/1471-2202/10/113
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ygenation, the intracellular localization of EndoG was
detected by immunocytochemistry; the morphologically
damaged neurons were identified by condensed and frag-
mented nuclei using DAPI nuclear staining. The result
revealed that EndoG was mainly located in the intracellu-
lar space out of the nucleus shown as red fluorescence in
normal control group or in EBSS-treated group under nor-
moxic condition (Figure 3A and 3B). Consistent with the
results from the previous western blot analysis, the
nuclear translocation of EndoG started at 2 h after reoxy-
genation and increased progressively (Figure 3C-E). Sig-
nificant numbers of neurons displaying EndoG nuclear
staining were observed 6 h after reoxygenation, a time
point when no obvious morphological neuronal damage
could be observed (Figure 3C and 3E). Thereafter,
although the number of morphologically damaged neu-
rons also increased with time, a great quantity of pyknotic
nuclei could not be observed until 12 h after reoxygena-
tion. Furthermore, the proportions of morphologically
damaged neurons were less than that of the EndoG trans-
located neurons at 12 h and 24 h, respectively (Figure 3D
and 3E). These results demonstrate that EndoG transloca-
tion from mitochondria to nucleus precedes neuronal cell
death.
BNIP3 mediates OGD-induced hippocampal neuronal 
death
To explore the role of BNIP3 in OGD-induced hippocam-
pal neuronal cell death, we first observed the expression of
BNIP3 following reoxygenation. Western blot analysis
revealed that BNIP3 bands with molecular weights of 30
kD (monomer) and 60 kD (dimer) started to increase at 2
h of reoxygenation (Figure 4A and 4B). We next examined
whether the expression of BNIP3 was sufficient to induce
neuronal death and also if BNIP3 was necessary to medi-
ate neuronal death after OGD. Hippocampal neurons
were transfected with pEGFP-C3-rBNIP3 plasmid or
pEGFP-C3 plasmid as a control. As shown in Figure 4C,
exogenous BNIP3 expression in normal cultured neurons
led to about 40% of cell death after transfection for 24 h.
To knockdown the expression of BNIP3, BNIP3-miRNA
construct was generated and co-transfected with pEGFP-
Translocation of EndoG from mitochondria to nuclei following reoxygenation Figure 2
Translocation of EndoG from mitochondria to nuclei following reoxygenation. (A) Representative western blot 
showing the level of mitochondrial EndoG. (B) Quantification of the level of mitochondrial EndoG. (C) Representative West-
ern blot showing the level of nuclear EndoG. (D) Quantification of the level of nuclear EndoG. Data were presented as fold of 
the control group. *p < 0.05 vs. control group, n = 6.BMC Neuroscience 2009, 10:113 http://www.biomedcentral.com/1471-2202/10/113
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C3-rBNIP3 plasmid encoding the full length of rat BNIP3
in HEK293 cells. The inhibition efficiency of BNIP3-
miRNA for BNIP3 expression was 80% compared with the
neg-miRNA transfected controls as identified by western
blot analysis (Figure 4D and 4E). Addition of BNIP3-
miRNA to hippocampal neurons significantly reduced
OGD-induced nuclear pyknosis when detected 12 and 24
h after reoxygenation (Figure 4F and 4G).
BNIP3 initiates the EndoG translocation
Finally, we tested the hypothesis that BNIP3 initiates the
translocation of EndoG to nucleus in OGD-induced neu-
ronal death. Because BNIP3 predominantly localizes to
the mitochondria and homodimerization appears to be a
feature of mitochondrial localization and important for
BNIP3's function [9], we explored the subcellular localiza-
tion of OGD-induced BNIP3. Immediately after reoxygen-
ation, upregulation of mitochondrial BNIP3 (dimer) was
detected, 2 h earlier than the EndoG translocation (Figure
5A and 5B). We next examined whether forced expression
of BNIP3 induced EndoG translocation. As shown in Fig-
ure 5C and 5D, the proportion of nuclear EndoG positive
staining neurons increased significantly in exogenous
BNIP3 expressing neurons compared to that in pEGFP-C3
transfected control neurons. Furthermore, we explored
whether knockdown of BNIP3 could reduce the OGD-
induced nuclear translocation of EndoG. Based on the
earlier result that EndoG began to significantly translocate
to nucleus at 2 h after reoxygenation, we wanted to
observe the effect that BNIP3 inhibition would have on
the percentage of neurons with nuclear EndoG at 2 h and
6 h after reoxygenation, respectively. Knockdown of
BNIP3 expression significantly reduced EndoG nuclear
translocation (Figure 5E and 5F).
Discussion
Recent biochemical and genetic studies have revealed that
EndoG is an important mitochondrial protein that ema-
nates from the mitochondria during apoptosis and facili-
tates degradation of nuclear chromatin [7,13]. The present
study, for the first time, strongly implies an essential role
of EndoG in post-ischemic hippocampal neuronal cell
death in vitro. Western blot analysis and immunocyto-
chemistry demonstrate that EndoG not only upregulates
in hippocampal neurons following reoxygenation but
also translocates from mitochondria to nucleus. This find-
ing is consistent with previous results on other ischemic
models, including cortical neuronal cultures subjected to
hypoxia [11], and cortical neurons of mice subjected to
transient or permanent focal cerebral ischemia [14,15].
Using subcellular fractionation with a detailed time
course, we confirmed that EndoG translocation markedly
precedes the appearance of biochemical markers of cell
death. The good temporal and spatial relationship
between EndoG translocation and nuclear pyknosis sug-
gests a causal role of EndoG translocation in OGD-
induced hippocampal neuronal death.
The present study also identifies BNIP3 and EndoG trans-
location as early events in hippocampal neurons sub-
jected to OGD. The increase in mitochondrial BNIP3
expression was observed immediately after reoxygena-
tion. The translocation of EndoG was detectable at 2 h
EndoG nuclear translocation preceded neuronal cell death  following reoxygenation Figure 3
EndoG nuclear translocation preceded neuronal cell 
death following reoxygenation. (A-D) Confocal laser 
scanning microscope images of EndoG immunoreactivity 
(red) at control, EBSS, OGD/R6 h, OGD/R24 h, respectively. 
Co-staining with DAPI (blue) allowed the identification of 
nuclear translocation of EndoG. The white arrow indicates 
the nucleus with EndoG translocation but without pyknosis, 
and the white arrowhead indicates the pyknotic nucleus with 
EndoG translocation; (E) Percentage of damaged neurons 
and neurons displaying nuclear EndoG at different time 
points following reoxygenation. *p < 0.05 vs. control group, 
n = 9.BMC Neuroscience 2009, 10:113 http://www.biomedcentral.com/1471-2202/10/113
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and increased significantly at 6 h after reoxygenation. This
is consistent with a previous report in a mouse model of
brain ischemia, in which EndoG translocation was
observed 4 h after transient focal cerebral ischemia [14].
Although in a previous study we found that BNIP3 and
EndoG translocation occurred relatively late in cultured
cortical neurons subjected to hypoxia [11], the mitochon-
drial translocation of the BNIP3 was before the nuclear
translocation of the EndoG in both studies, which
strongly supports that BNIP3 acts as an upstream signal of
EndoG. The discrepancy might result from either different
neuron types examined or different ischemic models
used. Compared with hypoxia, OGD is a more severe
stress to neurons and re-supply of oxygen and glucose
may further exacerbate the injury. In fact, we detected an
upregulation of BNIP3 in mitochondria at 0 h after reox-
BNIP3 is a mediator of OGD-induced hippocampal neuronal death Figure 4
BNIP3 is a mediator of OGD-induced hippocampal neuronal death. (A) Representative western blot showing the 
expression of BNIP3. (B) Quantification of the expression of BNIP3. Data were presented as fold of the control group. *p < 
0.05 vs. control group, n = 3. (C) Forced expression of BNIP3 by transfection with EGFP-C3-rBNIP3 plasmid in normal cul-
tured hippocampal neurons induced cell death. EGFP-C3 plasmid was transfected to neurons as a control. *p < 0.05, n = 21-29. 
(D-E) Inhibition efficiency of BNIP3-miRNA on BNIP3 expression in HEK293 cells co-transfected with indicated plasmids. *p < 
0.05 vs. neg-miRNA transfected control, n = 3. (F) Cultured neurons were transfected with BNIP3-miRNA or neg-miRNA 48 
h before OGD. Cell death of positive transfected neurons (green) was assessed by nuclear DAPI staining (blue) after OGD. 
Neurons pretreated with BNIP3-miRNA showed less pyknosis 12 h after reoxygenation compared with neg-miRNA treated 
neurons. (G) Quantification of experiments described in (F). Pretreatment with BNIP3-miRNA significantly reduced cell death 
compared with neg-miRNA treated controls. *p < 0.05 vs. control group, n = 21-26.BMC Neuroscience 2009, 10:113 http://www.biomedcentral.com/1471-2202/10/113
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BNIP3 initiates the nuclear translocation of EndoG following reoxygenation Figure 5
BNIP3 initiates the nuclear translocation of EndoG following reoxygenation. (A) Representative western blot show-
ing the expression of mitochondrial BNIP3. (B) Quantification of the expression of mitochondrial BNIP3. Data were presented 
as fold of the control group. *p < 0.05 vs. control group, n = 3. (C) EndoG (red) is located outside the DAPI-stained nucleus 
(blue) in EGFP-C3 transfected hippocampal neurons (left panel). EndoG translocated to the DAPI-stained nucleus in EGFP-C3-
rBNIP3 transfected hippocampal neurons (right panel). (D) Percentage of neurons displaying nuclear EndoG in EGFP-C3 and 
EGFP-C3-rBNIP3 transfected hippocampal neurons, respectively. Data was presented as the percentage of the transfected 
cells. *p < 0.05 vs. control group, n = 21-26. (E) EndoG translocated to the nucleus in neg-miRNA transfected hippocampal 
neurons (left panel) at 6 h after reoxygenation. EndoG located outside of the nucleus in BNIP3-miRNA transfected neurons 
(right panel) at 6 h after reoxygenation. Arrowhead showed that the EndoG still translocated to the nucleus in BNIP3-miRNA 
untransfected neurons (right panel) at 6 h after reoxygenation. (F) Percentage of neurons displaying nuclear EndoG in neg-
miRNA and BNIP3-miRNA transfected hippocampal neurons, respectively. Data are presented as the percentage of the posi-
tive transfected cells. *p < 0.05 vs. control group, n = 40-50.BMC Neuroscience 2009, 10:113 http://www.biomedcentral.com/1471-2202/10/113
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ygenation, which might imply that the mitochondrial
translocation of BNIP3 occurred and the signalling cas-
cade triggered by BNIP3 started during OGD. The expres-
sion of BNIP3 in mitochondria further increased with
prolonged reoxygenation, and knockdown of BNIP3
reduced cell death, supporting a role of BNIP3 in activat-
ing the cell death program. We also found that forced
expression of BNIP3 increased nuclear translocation of
EndoG. On the other hand, knockdown of BNIP3 expres-
sion reduced OGD-induced EndoG translocation. There-
fore, the present findings argue for the importance of
mitochondrial BNIP3 upregulation as an upstream mod-
ulator of EndoG translocation in ischemic neuronal
injury.
Conclusion
In the present study we provide the first detailed descrip-
tion of the time-dependent subcellular localization of
EndoG and BNIP3 in the cultured hippocampal neurons
following OGD. By exploring the temporal relationship
between the neuronal nuclear pyknosis and the transloca-
tion of the mitochondrial death-related proteins, BNIP3
and EndoG, we have been able to suggest an important
role of mitochondrial BNIP3 upregulation and EndoG
translocation in neuronal death. Combined with the find-
ings that forced expression of BNIP3 increases EndoG
translocation and neuronal death, and knockdown of
BNIP3 decreases EndoG translocation and neuronal
death, our results support the role of mitochondrial
BNIP3 as a signal protein upstream of EndoG leading to
the induction of neuronal death.
Methods
Animals
Neonatal 1 d Sprague-Dawley rats were provided by
Southern Medical University and conditions regarding
health and hygiene were confirmed. All experimental pro-
cedures in this study were performed within National
Institutes of Health guidelines for the care and use of lab-
oratory animals.
Cell culture and OGD
HEK293 cells were cultured in DMEM (Invitrogen) sup-
plemented with 10% heat-inactivated fetal calf serum and
2 mM glutamine. Primary hippocampal neuronal cultures
were prepared from neonatal Sprague-Dawley rats (P1) as
described previously [16]. Cells were cultured in Neuroba-
sal medium supplemented with 2% (v/v) B27, 2 mM
glutamine, and 100 U/ml penicillin/streptomycin (Invit-
rogen, San Diego, CA). Cultures contain > 95% neurons
as routinely controlled by neuronal-specific nuclear pro-
tein (NeuN) immunostaining. In 12- to 13-day-old pri-
mary neurons, the control culture medium was replaced
with Earl's balanced salt solution (EBSS) medium (in mg/
L: 6800 NaCl, 400 KCl, 264 CaCl2·2H2O, 200
MgCl2·7H2O, 2200 NaHCO3, 140 NaH2PO4·H2O, and
1000 glucose, pH 7.2). For OGD, glucose-free EBSS
medium was purged with N2/CO2/O2 (94%/5%/1%) for
30 min, resulting in an oxygen content of 2-3%. Neurons
were then washed three times with this medium and incu-
bated for 4 h in an oxygen-free N2/CO2/O2 (94%/5%/1%)
atmosphere. Thereafter, the medium was replaced by
standard culture medium (see above). Cells were collected
at 0, 2, 6, 12 and 24 h after reoxygenation respectively for
western blot analysis, immunocytochemistry and quanti-
fication of cell death.
Preparation of the mitochondrial and nuclear fractions
Mitochondrial protein was extracted according to the manu-
facturer's protocol (PIERCE). Nuclear fractions were pre-
pared as described by Yu et al. with slight modifications [17].
Briefly, the cells were washed and resuspended in isotonic
homogenization buffer (250 mM sucrose, 10 mM KCl, 1.5
mM MgCl2, 1 mM Na-EDTA, 1 mM Na-EGTA, 1 mM dithio-
threitol, 0.1 mM phenylmethylsulfonylfluoride, 10 mM Tris-
HCl, pH 7.4) containing a proteinase inhibitor cocktail (4-
(2-aminoethyl)benzenesulfonyl fluoride (AEBSF), pepsta-
tinA, E-64, bestatin, leupeptin, and aprotinin, Sigma). After
homogenization, the homogenate was trypsinized with
0.1% trypsin for 5 min, and the unbroken cells were spun
down. Then, the nuclei were fractionated at 80 × g for 10 min
from the supernatant and washed three times with homoge-
nization buffer containing 0.01% NP-40.
Western Blot analysis
Western blot analysis was performed as previously
described [18]. Protein samples (30 μg protein) were sep-
arated on 12% polyacrylamide gels and transferred to pol-
yvinylidene diflouride membrane. The membrane was
incubated with 5% skimmed milk in Tris-buffered saline
for 1 h to block nonspecific binding. The membrane was
then incubated overnight at 4°C with anti-EndoG anti-
body (1:500; Abcam), anti-BNIP3 (1:500; Sigma), anti-
COX IV (1:5000; Abcam) or anti-Histone H3 (1:5000;
BOSTER, Wuhan, China) and then further incubated with
horseradish peroxidase-conjugated secondary antibodies
(1:5000) for 1 h. Immunoblotting was detected by ECL
(Key GEN, Nanjing, China) and imaged on a FluorChem
8900 imager (Alpha Innotech). Western blot bands were
quantified using the FluorChem™ SP V.5.0.2.4 software.
Immunocytochemistry
Cultured cells were fixed with 4% formaldehyde in PBS
for 15 min and nonspecific binding was blocked for 60
min in PBS containing 0.3% Triton X-100 and 3% BSA.
Anti-EndoG antibody (1:50) was applied in PBS contain-
ing 0.3% Triton X-100, incubated overnight at 4°C, fol-
lowed by a Rhodamine (TRITC)-conjugated AffiniPure
Goat Anti-Rabbit IgG (H+L) (Jackson) secondary anti-
body (1:200) for 60 min. Negative controls, in which the
primary antibody was omitted, were similarly treated as
described above. Nuclear staining was followed with thePublish with BioMed Central    and   every 
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fluorescent DNA-binding dye 4', 6-diamidino-2-phe-
nylindole dihydrochloride (DAPI) (1:1000; Roche) for 15
min. Fluorescence pictures were taken on a Leica TCS SP2
scanning confocal microscope. Neurons with condensed
and fragmented nuclei were considered apoptotic. Five
randomly chosen visual fields were counted in each sam-
ple by an investigator blind to the experimental condi-
tions. About 500 cells from each group were counted.
BNIP3 gene silencing
Interfering plasmids targeting BNIP3 (BNIP3-miRNA)
were generated using BLOCK-iT Pol II miR RNAi Expres-
sion Vector Kits (Invitrogen) following the instructions of
the manufacturer. The miRNA sequences were designed
using Invitrogen's BLOCT-iT RNAi Designer. Briefly, the
oligonucleotides were synthesized, annealed and inserted
to the pcDNA6.2-GW/EmGFP-miR vector. The
pcDNA6.2/EmGFP-miR-neg control plasmid (neg-
miRNA) was used as a negative control.
Cell transfection
Neurons cultured for 7 days in vitro or HEK293 cells were
transfected with plasmids pEGFP-C3-rBNIP3, pEGFP-C3,
BNIP3-miRNA and neg-miRNA as we described previ-
ously [11] using Lipofectamine 2000 (Invitrogen) accord-
ing to manufacturer's recommendations.
Statistical analysis
All data are given as means ± SE if not indicated otherwise.
One-way ANOVA was used to test for overall statistical sig-
nificance. A difference was considered significant at P <
0.05.
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